-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse NasdaqUSDISIN US34960Q2084
ISIN US34960Q2084
WKN A2PYCP
Symbol FBIOP
Währung
USD
Börse
Nasdaq Zeitzone: Europe/Berlin
Firmenname
Fortress Biotech, Inc
Marktkapitalisierung
205.304.076 (+- 39%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
125.608.152 oder 285.000.000
Mitarbeiter
140 (+- 34%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
93 oder 187 Mitarbeiter
EBITDA -115.651.000
PEGRatio None
Buchwert 1.036
Fortress Biotech underperformed den DAX um -131 % vom 08.10.2013 bis 24.06.2021
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 24,93 USD -1,56%
Portrait der Fortress Biotech Aktie
Das Unternehmen Fortress Biotech, Inc aus USA beschäftigt 140 Mitarbeiter.
Die Fortress Biotech Aktie konnte seit dem 08.10.2013 leider keine Rendite erwirtschaften. Die Kursverluste lagen bei -49%.
Dir gefallen die Informationen zu Fortress Biotech?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Fortress Biotech?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Fortress Biotech?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Fortress Biotech?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
27 News & Informationen zur Fortress Biotech Aktie
Checkpoint Therapeutics Reports Second Quarter 2021 Financial Results
NEW YORK, Aug. 05, 2021 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted…
Journey Medical Partners Dr. Reddy's To Develop DFD-29 To Treat Rosacea – Quick Facts
(RTTNews) – Journey Medical Corp., a partner company of biopharmaceutical company Fortress Biotech, Inc. (FBIO), announced Wednesday an agreement …
Hedge Funds Are Selling Fortress Biotech Inc (FBIO)
Is Fortress Biotech Inc (NASDAQ:FBIO) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question…
Fortress Biotech : Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Fortress Biotech, Inc (Form 8-K)
CERTIFICATE OF AMENDMENT
OF
AMENDED AND RESTATED
CERTIFICATE OF INCORPORATION
OF
FORTRESS BIOTECH, INC.
… | June 24, 2021
Buying Penny Stocks; Is It Worth It? What to Know About Investing in Stocks Under $5
Why Fortress Biotech Stock Is Sinking Today
Investors were not thrilled with the company's latest regulatory update.
Mid-Afternoon Market Update: Dow Falls 75 Points; vTv Therapeutics Shares Spike Higher
Toward the end of trading Tuesday, the Dow traded down 0.22% to 33,669.76 while the NASDAQ rose 0.80% to 13,960.92. The S&P also rose, gaining…
Fortress Biotech dips after filing for 600K stock offering by selling shareholders
Fortress Biotech (FBIO) is trading ~6.0% in the post-market hours on the announcement of 600K common stockoffering by selling shareholders.Per the prospectus, the investors from time…
Is the Options Market Predicting a Spike in Fortress Biotech (FBIO) Stock?
Investors need to pay close attention to Fortress Biotech (FBIO) stock based on the movements in the options market lately.
28 Stocks Moving in Monday's Pre-Market Session
Gainers Wilhelmina International, Inc. (NASDAQ:WHLM) rose 73.6% to $9.65 in pre-market trading. Modell's Sporting Goods reported a stake of …
Fortress Biotech (FBIO) Surges 11.5%: Is This an Indication of Further Gains?
Fortress Biotech (FBIO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Fortress Biotech, Inc. Investors of Important January 26 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Fir
NEW YORK, Jan. 16, 2021 — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fortress Biotech, Inc. between December 11, 2019 and October 9, 2020,…
ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Fortress Biotech, Inc. Investors of Important January 26 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Fir
NEW YORK, Jan. 16, 2021 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fortress Biotech, Inc. (NASDAQ: FBIO) between December 11, 2019 and October 9, 2020, inclusive (the “Class Period”), of the important January 26, 2021 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Fortress investors under the federal securities laws. To join the Fortress class action, go to http://www.rosenlegal.com/cases-register-1997.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) intravenous (“IV”) Tramadol was not safe for the intended patient population; (2) as a result, it was foreseeable that the U.S. Food and Drug Administration would not approve the New Drug Application for IV Tramadol; and (3) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 26, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-register-1997.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com or cases@rosenlegal.com. NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. AN INVESTOR’S ABILITY TO SHARE IN ANY POTENTIAL FUTURE RECOVERY IS NOT DEPENDENT UPON SERVING AS LEAD PLAINTIFF. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/. Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm’s attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors. Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 lrosen@rosenlegal.com pkim@rosenlegal.com cases@rosenlegal.com http://www.rosenlegal.com
ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Fortress Biotech, Inc. Investors of Important January 26 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Fir
NEW YORK, Jan. 16, 2021 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fortress Biotech, …
IMPORTANT DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Fortress Biotech, Inc. – FBIO
NEW YORK, Jan. 12, 2021 (GLOBE NEWSWIRE) — Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased…
ROSEN, A LEADING AND LONGSTANDING LAW FIRM, Reminds Fortress Biotech, Inc. Investors of Important January 26 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to
NEW YORK, Jan. 9. 2021 /PRNewswire/ –?Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fortress Biotech, Inc. between December 11, 2019 and October…
ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Reminds Fortress Biotech, Inc. Investors of Important Deadline in Securities Class Action – FBIO
NEW YORK, Jan. 08, 2021 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fortress Biotech, …
Zhang Investor Law Reminds Investors with Losses of the Deadline in Securities Class Action Lawsuit Against Fortress Biotech, Inc. – FBIO
NEW YORK, Jan. 08, 2021 (GLOBE NEWSWIRE) — Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Fortress …
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fortress Biotech, Inc. (FBIO)
LOS ANGELES, Jan. 06, 2021 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming January 26, 2021 deadline to file a …
5 MicroCap Penny Stocks to Watch [Stocks under $5]
Fortress Biotech to Participate in Three January 2021 Virtual Investor Conferences
NEW YORK, Jan. 05, 2021 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (NASDAQ:FBIO) (“Fortress”), an innovative revenue-generating company focused on …
Mustang Bio to Participate in Three January 2021 Virtual Investor Conferences
WORCESTER, Mass., Jan. 05, 2021 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang”) (NASDAQ:MBIO), a clinical-stage biopharmaceutical company focused on …
DEADLINE ALERT for YY, LRN, and FBIO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
LOS ANGELES, Jan. 04, 2021 (GLOBE NEWSWIRE) — The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of …
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fortress Biotech, Inc. of Class Action Lawsuit and Upcoming Deadline – FBIO
NEW YORK, Jan. 3, 2021 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Fortress Biotech, Inc.?? and certain of its officers.? The class…
ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Fortress Biotech, Inc. Investors of Important January 26 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Cont
NEW YORK, Jan. 02, 2021 — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fortress Biotech, Inc. between December 11, 2019 and October 9, 2020,…
ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Fortress Biotech, Inc. Investors of Important January 26 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Cont
NEW YORK, Jan. 02, 2021 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fortress Biotech, Inc. (NASDAQ: FBIO) between December 11, 2019 and October 9, 2020, inclusive (the “Class Period”), of the important January 26, 2021 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Fortress investors under the federal securities laws. To join the Fortress class action, go to http://www.rosenlegal.com/cases-register-1997.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) intravenous (“IV”) Tramadol was not safe for the intended patient population; (2) as a result, it was foreseeable that the U.S. Food and Drug Administration would not approve the New Drug Application for IV Tramadol; and (3) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 26, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-register-1997.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com or cases@rosenlegal.com.NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. AN INVESTOR’S ABILITY TO SHARE IN ANY POTENTIAL FUTURE RECOVERY IS NOT DEPENDENT UPON SERVING AS LEAD PLAINTIFF.Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm’s attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors. Attorney Advertising. Prior results do not guarantee a similar outcome.\——————————-Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 lrosen@rosenlegal.com pkim@rosenlegal.com cases@rosenlegal.com www.rosenlegal.com
ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Fortress Biotech, Inc. Investors of Important January 26 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Cont
NEW YORK, Jan. 02, 2021 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fortress Biotech, …